Care New England is proud to offer you the cardiac care and expertise of Brigham and Women's Cardiovascular Associates at Care New England, made possible through a strong clinical affiliation between Care New England and Brigham and Women's Hospital in Boston.
While this advanced cardiac care is normally only found in major cities, we know people want it in a convenient local setting. Thanks to our clinical affiliation with Brigham and Women's Hospital, we can provide you with a team of cardiologists considered among the best in the region. They are available to meet all of your cardiac needs from the basic to the most complex.
These cardiologists keep office hours at a number of convenient locations throughout the state including Kent Hospital in Warwick, Care New England Medical Group Primary Care & Specialty Services in Pawtucket, and Women & Infants Hospital in Providence. Also, when appropriate, we can quickly arrange for the most advanced, world-class care at Brigham and Women's Hospital in Boston.
We have established a number of cardiac programs, ensuring patients receive the highest quality care. We work closely with our colleagues at Brigham and Women's Hospital, managing each and every case with a personalized approach. We also offer a support group to defibrillator/ICD patients.
Using specialized information technology (IT) and video-conferencing, this program allows physicians at Care New England facilities to communicate with their colleagues at Brigham & Women's Hospital about complex intensive care patients.
Care New England was awarded a Centers for Medicare and Medicaid Innovation Grant to develop a system-wide infrastructure that allows for improved communication and technology use between providers related to the care of patients with congestive heart failure. The goal of the program is to reduce hospital readmissions for congestive heart failure.
Care New England cardiovascular services has active clinical trials that are recruiting patients in such areas as arrhythmia, congestive heart failure and coronary artery disease.
One of the most important goals of the cardiovascular program at Care New England is to educate and support patients in their local communities. From "Day of Dance" celebrations related to women's cardiovascular health to support groups for defibrillator/ICD patients, Care New England cardiologists are committed to community service. Call (401) 681-4996 to learn more.
Our experienced Care New England Wellness Center team will work with you to create an individualized exercise program to meet your specific needs. An exercise physiologist will provide weekly blood pressure and heart rate readings, and ECG and glucose monitoring as needed. The cardiac maintenance team will educate you about nutrition, lifestyle modification and weight loss to help you on your journey to a healthier lifestyle. Please visit the Cardiac Wellness Program or call (401) 732-3066 to learn more.
From outpatient consultation to treatment in our Congestive Heart Failure Clinic to counseling for a heart transplant, Care New England is structured to care for you from diagnosis to treatment. With specialists like those from Brigham and Women's Cardiovascular Associates at Care New England, who provide a broad spectrum of cardiac services, you can rest assured that a personalized approach to your care will always be a priority.
Our general services include:
Exercise and pharmacological stress testing including:
We have consultative cardiology coverage 24 hours a day, seven days a week, 365 days a year. Our team of Care New England cardiologists also offers inpatient evaluations, outpatient evaluations at one of our convenient sites, preoperative assessment, diagnostic testing review and second opinions for complex cases.
Specially trained nurses staff the cardiac care units at the Care New England hospitals. One-on-one nursing care is provided for patients requiring cardiac intensive care treatments.
Diagnostic cardiac catheterization labs, essential to identifying the severity of coronary disease, are located at Kent, Memorial and Women & Infants hospitals. The technology makes your procedure (including trans-radial access) as safe as possible and reduces your exposure to radiation.
Our advanced services include:
We offer an array of advanced imaging modalities, including transesophageal echocardiography and vascular ultrasound imaging, to identify complex heart valve disease, advanced vascular ultrasound imaging, and cardiac CT technology to identify coronary disease and coronary calcium build-up.
This service, led by Dr. Bruce Koplan, provides a full range of consultative and procedural services focused on the heart's electrical system, including:
Led by Dr. Alice Kim, this service provides consultation for management of complex valvular heart disease and referrals for valve surgery or valve procedures.
This service, led by Dr. Garrick Stewart, provides a local resource for patients who have difficult cases of heart failure. Patients evaluated in this clinic can be considered for heart transplant or other procedures.
This service, led by Dr. Fred Wu, provides consultation for patients with pulmonary hypertension and symptoms that might require advanced medical or interventional management. This clinic also serves adult patients with a history of congenital heart disease requiring local follow up.
The Brigham and Women's Cardiovascular Associates at Care New England offer a variety of clinical trials - some of which make cutting edge treatments available - to patients who meet eligibility requirements.
For more information on any of these studies or to see if you qualify, please call 401-681-4996.
This study aims to determine whether an invasive strategy (routine early cardiac catheterization with intent for optimal revascularization) in addition to optimal medical therapy reduces the incidence of the composite of cardiovascular death or nonfatal myocardial infarction compared with a conservative strategy of optimal medical therapy alone (cardiac catheterization and revascularization reserved for patients with refractory angina, ACS, acute ischemic HF or resuscitated cardiac arrest).
This study aims to determine whether ranolazine administration will decrease the likelihood of a composite arrhythmia endpoint consisting of ventricular tachycardia or ventricular fibrillation (VT/VF) requiring ATP therapy, ICD shocks, or death. Patients will receive either ranolazine or placebo during the trial.
The study population will consist of patients with ischemic or non-ischemic cardiomyopathy with existing devices (ICD/CRT-D) and meet the criteria listed below:
The purpose of this study is to evaluate the efficacy, safety, and tolerability of IV serelaxin when added to standard therapy in acute heart failure (AHF) patients. The primary objective is to demonstrate that serelaxin is superior to placebo in reducing CV death in acute heart failure patients during a follow-up period of 180 days.
The study population will consist of patients admitted to the hospital for AHF with mild to moderate renal impairment. Patients will be randomized within 16 hours from presentation to hospital/ER.
This is an Investigator Sponsored Research (ISR) program funded by Gilead Sciences. The purpose of this study is to determine if Ranolazine, through a reduction in PVC burden, can manifest beneficial effects on coronary ischemia.